Marta Lorenzo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Journal: Theranostics

Published: December 10, 2025

Uncovering the role of ETS2 in prostate cancer pathogenesis: relationship with p53 and ERG.

Uncovering the role of ETS2 in prostate cancer pathogenesis: relationship with p53 and ERG.

Journal: Molecular biology reports

Published: September 01, 2025

Integrating Optical Genome Mapping With TP53 FISH: A Synergistic Approach for Cytogenomic Analysis in Chronic Lymphocytic Leukemia.

Integrating Optical Genome Mapping With TP53 FISH: A Synergistic Approach for Cytogenomic Analysis in Chronic Lymphocytic Leukemia.

Journal: American journal of hematology

Published: February 04, 2025

Complex Karyotype Detection in Chronic Lymphocytic Leukemia: A Comparison of Parallel Cytogenetic Cultures Using TPA and IL2+DSP30 from a Single Center.

Complex Karyotype Detection in Chronic Lymphocytic Leukemia: A Comparison of Parallel Cytogenetic Cultures Using TPA and IL2+DSP30 from a Single Center.

Journal: Cancers

Published: April 30, 2024

Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.

Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: July 26, 2023

Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.

Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.

Journal: Virchows Archiv : an international journal of pathology

Published: January 17, 2019

SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.

SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.

Journal: The Prostate

Published: January 07, 2019

Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.

Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.

Journal: Virchows Archiv : an international journal of pathology

Published: December 27, 2018

Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.

Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.

Journal: Clinical lung cancer

Published: November 09, 2018

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.

Journal: Clinical lung cancer

Published: January 09, 2017

CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.

CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.

Journal: Histopathology

Published: October 21, 2016

FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.

FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.

Journal: Human pathology

Published: August 11, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026